FDA Inspection 1207909 — Quagen Pharmaceuticals LLC
The FDA completed an inspection of Quagen Pharmaceuticals LLC on May 9, 2023 in West Caldwell, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 9, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- West Caldwell, NJ (United States)